1 | Robert Heron (PDF 64 KB) |
| eb93458b-9d6f-42a5-b60b-0dbdc64f3b1c~691263 |
2 | Rachel Rogers (PDF 67 KB) |
| 5b236b19-eb10-471b-a408-16a7ac51341d~691386 |
3 | Recordati Rare Diseases Australia (PDF 1339 KB) |
| 63c2925e-696f-4fff-9f4f-39de95eb5214~691689 |
4 | Fabry Australia (PDF 5719 KB) |
| b374f073-fe83-4ae8-b96a-f7930cf76a2f~691809 |
5 | Ms Julia Burlison (PDF 72 KB) |
| 7eeca763-af2a-48f8-981f-0903bc5823d1~691952 |
6 | Mrs Donna Greenhalgh (PDF 118 KB) |
| f6860794-498d-4262-8a13-b5da61880bce~692043 |
7 | Specialised Therapeutics Australia (PDF 2325 KB) |
| 18c69146-cd9b-4598-883a-7c80b1f0f09b~692355 |
8 | Cystic Fibrosis Australia (PDF 3140 KB) |
| 5227f33b-2147-4b37-8753-4aacb567245f~692266 |
9 | Mind Medicine Australia (PDF 455 KB) |
| 4ce3fb0d-423b-4bbf-825e-11575505c00c~692276 |
10 | Mirum Pharmaceuticals (PDF 227 KB) |
| c27bbb70-082e-47cc-a9d2-19c331c0937d~692309 |
11 | MPNAA (PDF 122 KB) |
| 82901921-264b-474b-8022-93d083227b12~692318 |
12 | Myeloma and Related Diseases Registry (PDF 129 KB) 12.1 Supplementary to submission 12 (PDF 153 KB) |
| dad4c017-95a5-4831-8ad3-27d76af587dc~692321|c108d6d9-9dd7-4725-9b4a-e0512c789ca7~692321 |
13 | Mr Michael Smith (PDF 1454 KB) |
| 8fcdc8a7-f360-43c1-ac02-59d63b4b0b2b~692328 |
14 | Confidential |
| |
15 | Department of Health (PDF 466 KB) 15.1 Supplementary to submission 15 (PDF 419 KB) 15.2 Supplementary to submission 15 (PDF 37 KB) 15.3 Supplementary to submission 15 (PDF 100 KB) 15.4 Supplementary to submission 15 (PDF 634 KB) 15.5 Supplementary to submission 15 (PDF 1187 KB) 15.6 Supplementary to submission 15 (PDF 1471 KB) 15.7 Supplementary to submission 15 (PDF 241 KB) |
| 31af4ba8-5add-4891-8b85-085adc90ba33~693488|616455e6-0388-4a4c-aa53-ce3514fd9b83~693488|1bde181c-1614-45d0-b6a6-71afa0ecc832~693488|77e054f0-5a45-4c48-baf3-2530adef96b3~693488|d5c5dfd7-6abc-4f23-823b-b59a95f7f355~693488|2b780c3b-424b-4581-bf40-e6a3077675dc~693488|89d4f97d-7674-4f0e-a282-398b4951170b~693488|188c7ebf-762f-4432-b34f-ba481054d178~693488 |
16 | Australasian Sleep Association (PDF 127 KB) |
| 58103a21-0931-40e0-bbe9-839814d40030~692278 |
17 | Dr Falk Pharma Australia Pty Ltd (PDF 829 KB) |
| ddf53c3c-3849-4884-81ea-2da8dac13727~692281 |
18 | QIMR Berghofer (PDF 291 KB) |
| 84a2e221-d665-4062-b561-1dbe71e24c3f~693553 |
19 | PFIC Network (PDF 192 KB) |
| 7a3c9b9e-a778-4449-abdb-52e7b9da2ee0~693378 |
20 | Confidential |
| |